A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2009
11/25/2009	EP2121036A2 Meganuclease variants cleaving a dna target sequence from the beta-2-microglobulin gene and uses thereof
11/25/2009	EP2121035A2 Transfection in magnetically driven continuous flow
11/25/2009	EP2121034A1 Use of sirt7 for treating age-related diseases
11/25/2009	EP2120998A2 Modified erythropoietin polypeptides and uses thereof for treatment
11/25/2009	EP2120926A1 Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
11/25/2009	EP1210108B1 Use of leptin together with an inhibitor of vegf and/or an inhibitor of angiogenesis for the inhibition of endothelial cell proliferation
11/25/2009	EP1019490B1 Methods for modulating hematopoiesis and vascular growth
11/25/2009	EP0954585B1 Human telomerase reverse transcriptase promoter
11/25/2009	CN101588821A Oligonucleotide non-viral delivery systems
11/25/2009	CN101586167A Diagnosis reagent for primary hepatocellular carcinoma, reagent kit and prevention and cure medicaments
11/25/2009	CN101586142A Research approach for element for forcing knubble microenvironment and application thereof
11/25/2009	CN101586115A Gene coexpression recombinant plasmid and DNA vaccine prepared from same
11/25/2009	CN101586114A CEA positive regulation IL-15 tumor immunity gene therapy plasmid vector and application thereof
11/25/2009	CN101586106A The genome of the hiv-1 inter-subtype (c/b') and use thereof
11/25/2009	CN101586096A Recombinant virus with coexpression of anthropogenic glutamate decarboxylase and cell factor
11/25/2009	CN101585882A Fusion protein for treating breast cancer and application thereof
11/25/2009	CN101584869A Method of differentiating/inducing bone marrow interstitial cells into nerve cells and skeleton muscle cells by transferring notch gene
11/25/2009	CN101584868A Application of NPTX gene on preparation of antineoplastic medicaments
11/25/2009	CN101584862A Diagnosing tumorigenicity and determining resistance to anticancer therapy
11/25/2009	CN100562570C Modified recombinant vaccinia viruses and other microorganisms, uses thereof
11/25/2009	CN100562342C Oligonucleotide drug for preventing and treating influenza virus infection
11/25/2009	CN100562311C Cisplatin preparation method and its application method
11/24/2009	US7622557 Obtaining a cell sample which contains a stem cell; detecting the expression of BCRP by a cell in the cell sample; wherein a cell that expresses BCRP is identified as a stem cell
11/24/2009	US7622556 Modified cytokines for use in cancer therapy
11/24/2009	US7622549 Human telomerase reverse transcriptase polypeptides
11/24/2009	US7622530 Biocompatible block copolymer comprising one or more elastomeric blocks and one or more thermoplastic blocks connected by a seed polymer
11/24/2009	US7622457 Polynucleotides encoding anticoagulant fusion proteins
11/24/2009	US7622455 Methods for slowing familial ALS disease progression
11/24/2009	US7622454 RNAi inhibition of CTGF for treatment of ocular disorders
11/24/2009	US7622453 Oligomeric compounds for the modulation of Bcl-2
11/24/2009	US7622442 Interacting the immature dendritic cells with an antigen ex vivo so that the surface antigen is presented; inducing maturation ex vivo; and contacting with a modulator comprising TRANCE; an increased viability relative to a control dendritic cell not contacted with TRANCE
11/24/2009	US7622280 Silicone based surfactant comprising hydrophobic and hydrophilic phases containing functional in vitro eukaryotic expression systems; compartmentalisation of transcription/translation reactions
11/24/2009	US7622269 Methods of screening tyramine- and octopamine-expressing cells for compounds and compositions having potential insect control activity
11/24/2009	US7622127 Clostridial toxin derivatives and methods for treating pain
11/24/2009	US7622122 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex
11/24/2009	US7622119 Wilm's tumor amino acid sequences for use as tissue targeted agent for treatment of cell proliferative disorders
11/24/2009	US7622110 Using interleukin beta specific immunoglobulin as blocking agent and preventative of juvenile idiopathic arthritis
11/24/2009	CA2423384C New cross-linked derivatives of hyaluronic acid
11/24/2009	CA2413337C Bioadhesive compositions and methods of preparation and use
11/24/2009	CA2338342C Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents
11/24/2009	CA2321938C Poly zinc finger proteins with improved linkers
11/24/2009	CA2265912C Human bad polypeptides, encoding nucleic acids and methods of use
11/24/2009	CA2257127C Inhibition of ii synthesis
11/24/2009	CA2201105C Inhibitor of stem cell proliferation and uses thereof
11/19/2009	WO2009140676A2 Compositions and methods for inhibition of retroviruses
11/19/2009	WO2009140649A2 Rab3b for the treatment and prevention of parkinson's disease
11/19/2009	WO2009140626A2 Long term disease modification using immunostimulatory oligonucleotides
11/19/2009	WO2009140572A2 Combinatorial treatment with glucose regulated protein-170 and melanoma differentiation associated gene-7
11/19/2009	WO2009140432A2 Micelles for intracellular delivery of therapeutic agents
11/19/2009	WO2009140429A2 Micellic assemblies
11/19/2009	WO2009140427A2 Diblock copolymers and polynucleotide complexes thereof for delivery into cells
11/19/2009	WO2009140421A2 Polymeric carrier
11/19/2009	WO2009140382A2 Treatment of hearing and balance impairments using compounds having erythropoietin activity
11/19/2009	WO2009139887A2 Non-inflammatory gluten peptide analogues as biomarkers for celiac sprue
11/19/2009	WO2009139876A2 Regenerating and enhancing development of muscle tissue
11/19/2009	WO2009139459A1 Method for prevention and treatment of metabolic syndrome through the inhibition of psgl-1
11/19/2009	WO2009137872A1 Methods and compositions for the treatment of cancer
11/19/2009	US20090286969 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs
11/19/2009	US20090286860 Method of using adenoviral vectors to induce an immune response
11/19/2009	US20090286858 Assays for modulators of asparaginyl hydroxylase
11/19/2009	US20090286854 Aptamers directed to muci
11/19/2009	US20090286853 Modified oligonucleotides for telomerase inhibition
11/19/2009	US20090286852 RNA containing modified nucleosides and methods of use thereof
11/19/2009	US20090286721 Targeted plasminogen activator fusion proteins as thromobolytic agents
11/19/2009	US20090286720 Pharmaceutical composition for the diagnosis, prevention or treatment of a tumoral pathology comprising an agent modulating the polymerization state of actin
11/19/2009	US20090286316 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
11/19/2009	US20090286311 DNA sequences for the expression of alloproteins
11/19/2009	US20090285843 Epitope sequences
11/19/2009	US20090285825 Novel snake toxin
11/19/2009	US20090285822 Prevention and treatment of amyloidogenic disease
11/19/2009	US20090285817 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
11/19/2009	US20090285816 Albumin Fusion Proteins
11/19/2009	US20090285814 CD 40 Binding Molecules and CTL Pepetides for Treating Tumors
11/19/2009	US20090285809 Prevention and treatment of amyloidogenic diseases
11/19/2009	US20090285791 Regenerating and enhancing development of muscle tissue
11/19/2009	US20090285788 RANDOM RNAi LIBRARIES, METHODS OF GENERATING SAME, AND SCREENING METHODS UTILIZING SAME
11/19/2009	US20090285783 Methods and compositions for cancer therapy using a novel adenovirus
11/19/2009	US20090285777 Uses of Mammalian Cytokine; Related Reagents
11/19/2009	DE102008029669A1 Neue Therapeutika für die Hepatitis-Therapie New therapeutics for the treatment of hepatitis
11/19/2009	DE102008023913A1 Composition, useful e.g. transfection comprises a non-viral gene delivery system containing e.g. cationic lipid, and an agent for partial suppression and/or activation of innate intracellular and/or intercellular immune defense
11/19/2009	DE102008016275A1 Composition, useful e.g. transfection comprises a non-viral gene delivery system containing e.g. cationic lipid, and an agent for partial suppression and/or activation of innate intracellular and/or intercellular immune defense
11/19/2009	CA2760041A1 Methods and compositions for the treatment of cancer
11/19/2009	CA2724472A1 Micelles for intracellular delivery of therapeutic agents
11/19/2009	CA2724455A1 Polymeric carrier
11/19/2009	CA2724418A1 Long term disease modification using immunostimulatory oligonucleotides
11/19/2009	CA2724105A1 Diblock copolymers and polynucleotide complexes thereof for delivery into cells
11/19/2009	CA2724014A1 Micellic assemblies
11/18/2009	EP2119785A1 Novel peptides
11/18/2009	EP2119784A2 Method and compositions for cellular reprogramming
11/18/2009	EP2119738A1 Polyethylene glycol derivative
11/18/2009	EP2119450A2 Induction of mucosal tolerance to antigens
11/18/2009	EP2119448A1 High affinity binding site of HGFR and methods for identification of antagonists thereof
11/18/2009	EP2118318A2 Gnaq mutations in melanoma
11/18/2009	EP2117602A2 Radioimmunotherapy and imaging of tumor cells that express viral antigens
11/18/2009	EP2117599A1 Membrane(s) and uses thereof
11/18/2009	EP2117557A2 Compositions and methods for treatment of colorectal cancer
11/18/2009	EP2117304A2 Methods and compositions for modulating sialic acid production and treating hereditary inclusion body myopathy
11/18/2009	EP1711518B1 Chimpanzee adenovirus vaccine carriers
11/18/2009	EP1499349B1 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
11/18/2009	EP1453977B1 Molecular characteristics of non-small cell lung cancer

1 ... 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 ... 870